Kovler Diabetes Center welcomed more than 120 patients and family members at this year's Monogenic Diabetes Family Forum, June 23-25
This year, Kovler Diabetes Center is celebrating its 10th anniversary, capping a decade of cutting-edge patient care and research notable for its leading role in identifying new genes for diabetes and using genetic information to drive clinical decision making.
The celebration of this milestone will look ahead to the next 10 years, building on a long tradition of accomplishments in diabetes research at the University of Chicago based on scientific advances that impact patient care. These include the discovery of the pathways of insulin biosynthesis and secretion by Donald Steiner, Professor of Biochemistry and Molecular Biology, and the demonstration by Arthur Rubenstein, Professor of Medicine, that the measurement of byproducts of the insulin secretory pathway (proinsulin, C-peptide and other peptides) provides important insights into the health of the pancreatic beta cell and alterations in disease. Other advances include the development of methods to accurately measure pancreatic beta cell function in humans and the identification of diabetes susceptibility genes led by Graeme Bell, Professor of Medicine.
The establishment of the Kovler Diabetes Center by a transformative gift from Jonathan Kovler and the Kovler Family Foundation has allowed us, under the leadership of Lou Philipson, Professor of Medicine, to organize diabetes care more comprehensively into a center that includes endocrinology and various specialties essential for optimal diabetes care, including podiatry, cardiology, ophthalmology, nephrology, psychology and neurology. The gift from the Kovler family gave the new center an identity and a space dedicated to all aspects of diabetes care. We are deeply grateful to Jonathan Kovler for his generosity and also to his wife, Sally, whose leadership of the Kovler Diabetes Center Board has raised funds to support the ongoing needs of the Center.
Unfortunately, the epidemic of diabetes in our country continues unabated. At any given time, almost 30 percent of UCMC inpatients have some form of diabetes, and the economic and public health costs to our community are enormous. Cutting-edge research and innovative treatment have never been more important. Congratulations to Lou Philipson and the physicians and staff who work in the Kovler Diabetes Center for a very productive first 10 years. We are confident that the next 10 years will be equally successful.